| 产品编号 | CFN95696 | |
| CAS编号 | 373646-49-2 | |
| 分子式 = 分子量 | C50H50O21 = 986.9 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Phenylpropanoids | |
| 植物来源 | The roots of Polygala tenuifolia | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| Lapathoside A | CFN95696 | 373646-49-2 | 1mg | QQ客服:3257982914 |
| Lapathoside A | CFN95696 | 373646-49-2 | 5mg | QQ客服:3257982914 |
| Lapathoside A | CFN95696 | 373646-49-2 | 10mg | QQ客服:3257982914 |
| Lapathoside A | CFN95696 | 373646-49-2 | 20mg | QQ客服:3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA. |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.0133 mL | 5.0664 mL | 10.1327 mL | 20.2655 mL | 25.3318 mL |
| 5 mM | 0.2027 mL | 1.0133 mL | 2.0265 mL | 4.0531 mL | 5.0664 mL |
| 10 mM | 0.1013 mL | 0.5066 mL | 1.0133 mL | 2.0265 mL | 2.5332 mL |
| 50 mM | 0.0203 mL | 0.1013 mL | 0.2027 mL | 0.4053 mL | 0.5066 mL |
| 100 mM | 0.0101 mL | 0.0507 mL | 0.1013 mL | 0.2027 mL | 0.2533 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid; 2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid | CFN89112 | 176983-21-4 | C30H46O5 = 486.69 | 5mg | QQ客服:3257982914 |
| 9-甲氧基没药酮; 9-Methymyrrhone | CFN91041 | 1809980-22-0 | C16H18O3 = 258.31 | 5mg | QQ客服:1413575084 |
| Massonianoside A; Massonianoside A | CFN95708 | 623945-11-9 | C25H32O10 = 492.5 | 5mg | QQ客服:2159513211 |
| 1-(4,7-Dimethoxy-1,3-benzodioxol-5-yl)-1-propanone; 1-(4,7-Dimethoxy-1,3-benzodioxol-5-yl)-1-propanone | CFN95928 | 107882-48-4 | C12H14O5 = 238.2 | 5mg | QQ客服:1413575084 |